Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ProShares Trust (NASDAQ: ZBIO).

Full DD Report for ZBIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ZBIO)

Drug Pricing Reform Continues
By Ethan Lovell Portfolio Manager Ethan Lovell discusses a new proposal to overhaul drug pricing in Medicare Part B and what it could mean for drug manufacturers. Key Takeaways A proposal to lower drug costs would align Medicare Part B drug prices with prices outside the U.S., wher...
Source: SeekingAlpha
Date: November, 02 2018 05:35
The Biotech Bumps
We've turned the page to November, and investors across the globe may feel a bit of unconscious relief. Stock markets do fluctuate, but months like October are never fun. And that has been especially acute in biotech. Leading ETFs like IBB and XBI dropped ~15% and 18% respectively in October...
Source: SeekingAlpha
Date: November, 01 2018 08:00
President promises lower drug prices
Speaking at the Department of Health & Human Services, the president says both consumers and the government can save money if drugs were priced along the lines of that of other countries (i.e., Canada). More news on: iShares Nasdaq Biotechnology ETF, Health Care Select Sect SPDR ETF,...
Source: SeekingAlpha
Date: October, 25 2018 14:32
New Innovation Spurring A Biotech Rejuvenation
By Evan McCulloch, Senior Vice President, Director of Research Franklin Equity Group ® Portfolio Manager, Franklin Biotechnology Discovery Fund Franklin Equity Group's Evan McCulloch explains why higher rates of drug utilization and healthcare spending are lending support to the b...
Source: SeekingAlpha
Date: September, 26 2018 06:26
Welcome To The Formula - A Biotechnology Marketplace
(Editors' Note: This article is meant as an introduction for The Formula , a new Marketplace service by Clover Biotech Research.) The Formula Welcome To Seeking Alpha's Next Big Community! Your subscription and confidence in our service are important to me. While I cannot promise por...
Source: SeekingAlpha
Date: September, 04 2018 10:00
Biotech: Take It On The Run
A recent study from Cowen Research says that biotech investors shouldn’t count on sell-side analysts’ ratings of stocks in the sector. In fact, biotech investors should do the exact opposite of their recommendations, and buy when analysts say sell, and vice versa. According to ...
Source: SeekingAlpha
Date: July, 05 2018 07:30
Can frothy biotech IPO pace keep up
Six biotech companies went public over just a three-day period this week, and three more are expected before June comes to a close. More news on: iShares Nasdaq Biotechnology ETF, SPDR Biotech ETF, Direxion Daily S&P Biotech Bull 3x Shares ETF, Healthcare stocks news, News on ETFs, ...
Source: SeekingAlpha
Date: June, 22 2018 12:07
Healthcare Industries Are About To Experience An Entire Transformation
Healthcare and all its many sectors including insurance are about to see a massive campaign to attack the exorbitant cost of healthcare in this country. How appropriate, seeing we are getting early indications from the CBO that Obama Care premiums will increase another 15% on average throughou...
Source: SeekingAlpha
Date: June, 14 2018 16:22
ProShares announces ETF share splits
ProShares announced splits on ETF: More news on: ProShares Ultra MidCap 400 ETF, ProShares Ultra Financials ETF, ProShares Ultra Dow 30 ETF, News on ETFs, Read more ...
Source: SeekingAlpha
Date: May, 10 2018 13:28
ProShares announces splits, reverse splits on 20 ETFs
The following are forward splitting shares 3-for-1 after the close on May 23: ProShares Ultra S&P MidCap400 (NYSEARCA: MVV ), ProShares Ultra Financials (NYSEARCA: UYG ), ProShares Ultra Dow30 (NYSEARCA: DDM ), ProShares Ultra MSCI EAFE (NYSEARCA: EFO ), ProShare...
Source: SeekingAlpha
Date: May, 09 2018 16:43

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0814.2314.2914.440914.0322,252
2018-05-179.7869.779.9319.7723,959
2017-03-1015.7816.0416.0915.7510,911
2017-03-0916.3216.1116.5015.922419,382
2017-03-0816.8016.2016.8015.824391,787

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-142,2753,59663.2647Short
2018-12-134391,11039.5495Short
2018-12-125931,33344.4861Short
2018-12-1113623757.3840Short
2018-12-106721,48645.2221Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZBIO.


About ProShares Trust (NASDAQ: ZBIO)

Logo for ProShares Trust (NASDAQ: ZBIO)

Not available

 

Contact Information

 

 

Current Share Structure

     



    Daily Technical Chart for (NASDAQ: ZBIO)

    Daily Technical Chart for (NASDAQ: ZBIO)


    Stay tuned for daily updates and more on (NASDAQ: ZBIO)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: ZBIO)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ZBIO and does not buy, sell, or trade any shares of ZBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/